3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematologic Neoplasms
4
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasms
1
Mental Disorders
1
Lung Neoplasms
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Malignant Solid Neoplasm
1
Interventions
Practice Guidelines as Topic
5
Standard of Care
4
Specimen Handling
3
Docetaxel
3
pertuzumab
2
Trastuzumab
2
Taxes
2
Paclitaxel
2
Minoxidil
2
Methods
2
Interviews as Topic
2
High-Energy Shock Waves
2
Educational Status
2
Early Intervention, Educational
2
Biopsy
2
trastuzumab biosimilar HLX02
1
Yoga
1
Transcutaneous Electric Nerve Stimulation
1
Radiation Dose Hypofractionation
1
Palliative Care
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Nutrition Assessment
1
Mental Status and Dementia Tests
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Goserelin
1
Geriatric Assessment
1
Genetic Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage I Breast Cancer AJCC v8
×
Behavior Therapy
×
90 days
×
Clear all
No trials found.